Intuitive Surgical’s stock has been hammered by the recent inflow of negative reports regarding the safety and cost-benefits of its da Vinci Surgical system. A new study by Columbia University suggests that surgery through the system costs significantly higher than the standard minimally invasive procedure, and that too without any major benefits. Then the news of the FDA surveying surgeons at major hospitals to list complications witnessed with the surgical system further triggered selling in the stock. …read more
Source: FULL ARTICLE at Forbes Latest